GABriella Virtual Investigator Meeting

Date: 04-Sept 2025

Times:

South Korea and Europe: 4:00–5:00 PM KST / 8:00–9:00 AM BST

Chile and Europe: 9:00–10:00 AM EDT / 2:00–3:00PM BST

Welcome and Introductions

Peter Deaton

Study Lead, Program Chapter, pRED Clinical Operations

10 mins

Nivegacetor in context: MoA, clinical journey, GABriella study design and recruited population

Rosanna Tortelli

Senior Principal Medical Director and Clinical Expert Team Leader

5 mins

Safety update: nivegacetor profile (RO7269162)

Tianxu Yang

Medical Safety Director

Christoph Wandel

Safety Stratgey Lead

10 mins

IMP compliance

Irma Kurniawan

Clinical Scientist

10 mins

Interim analysis 3 and upcoming milestones

Petr Novak

Clinical Scientist

Natasha O'Sullivan

Programme Lead

10 mins

Q&A

All

10 mins

Meeting close

Peter Deaton

Study Lead, Program Chapter, pRED Clinical Operations

5 mins